4-butyrolactone has been researched along with clozapine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Salama, AI; Saller, CF | 1 |
| Chrapusta, SJ; Egan, MF; Karoum, F; Wyatt, RJ | 1 |
2 other study(ies) available for 4-butyrolactone and clozapine
| Article | Year |
|---|---|
3-Methoxytyramine accumulation: effects of typical neuroleptics and various atypical compounds.
Topics: 4-Butyrolactone; Animals; Antipsychotic Agents; Apomorphine; Benzazepines; Buspirone; Carbazoles; Chlorpromazine; Clozapine; Corpus Striatum; Dopamine; Dopamine Antagonists; Fluphenazine; Haloperidol; Male; Molindone; Pargyline; Pyrimidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Regression Analysis | 1986 |
Haloperidol and clozapine increase intraneuronal dopamine metabolism, but not gamma-butyrolactone-resistant dopamine release.
Topics: 3,4-Dihydroxyphenylacetic Acid; 4-Butyrolactone; Animals; Brain Chemistry; Cerebral Cortex; Clozapine; Dopamine; Dopamine Antagonists; Haloperidol; Homovanillic Acid; Male; Neurons; Rats; Rats, Sprague-Dawley; Receptors, Dopamine | 1993 |